Ambev SA has a consensus price target of $2.2, established from looking at the 8 latest analyst ratings. The last 3 analyst ratings were released from Barclays, Jefferies, and Bernstein on March 4, 2024, November 22, 2023, and May 24, 2023. With an average price target of $3.2 between Barclays, Jefferies, and Bernstein, there's an implied 37.34% upside for Ambev SA from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/04/2024 | ABEV | Buy Now | Ambev | $2.33 | 28.76% | Barclays | Benjamin Theurer | $3.5 → $3 | Downgrade | Overweight → Equal-Weight | Get Alert |
11/22/2023 | ABEV | Buy Now | Ambev | $2.33 | 22.75% | Jefferies | Alex Wright | → $2.86 | Initiates | → Hold | Get Alert |
05/24/2023 | ABEV | Buy Now | Ambev | $2.33 | 60.52% | Bernstein | Nadine Sarwat | → $3.74 | Initiates | → Outperform | Get Alert |
07/13/2022 | ABEV | Buy Now | Ambev | $2.33 | — | JP Morgan | Lucas Ferreira | — | Upgrade | Neutral → Overweight | Get Alert |
11/03/2021 | ABEV | Buy Now | Ambev | $2.33 | — | B of A Securities | — | — | Upgrade | Underperform → Neutral | Get Alert |
10/06/2021 | ABEV | Buy Now | Ambev | $2.33 | 50.21% | Barclays | Benjamin Theurer | — | Upgrade | Equal-Weight → Overweight | Get Alert |
06/17/2021 | ABEV | Buy Now | Ambev | $2.33 | 71.67% | Barclays | Benjamin Theurer | — | Upgrade | Underweight → Equal-Weight | Get Alert |
05/20/2021 | ABEV | Buy Now | Ambev | $2.33 | 54.51% | Itau BBA | Andre Hachem | — | Downgrade | Outperform → Market Perform | Get Alert |
The latest price target for Ambev (NYSE: ABEV) was reported by Barclays on March 4, 2024. The analyst firm set a price target for $3.00 expecting ABEV to rise to within 12 months (a possible 28.76% upside). 3 analyst firms have reported ratings in the last year.
The latest analyst rating for Ambev (NYSE: ABEV) was provided by Barclays, and Ambev downgraded their equal-weight rating.
The last upgrade for Ambev SA happened on July 13, 2022 when JP Morgan raised their price target to N/A. JP Morgan previously had a neutral for Ambev SA.
The last downgrade for Ambev SA happened on March 4, 2024 when Barclays changed their price target from $3.5 to $3 for Ambev SA.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ambev, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ambev was filed on March 4, 2024 so you should expect the next rating to be made available sometime around March 4, 2025.
While ratings are subjective and will change, the latest Ambev (ABEV) rating was a downgraded with a price target of $3.50 to $3.00. The current price Ambev (ABEV) is trading at is $2.33, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.